Zevra Therapeutics, Inc. (ZVRA) PT Lowered to $20 at Canaccord
Tweet Send to a Friend
(Updated - July 27, 2026 6:31 AM EDT)
Canaccord analyst Sumant Kulkarni lowered the price target on Zevra Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst Sumant Kulkarni lowered the price target on Zevra Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
